| Literature DB >> 18679181 |
R M Conti1, D O Meltzer, M J Ratain.
Abstract
Nonprofit biomedical firms are an integrated market-based solution to improve incentives for investment in promising scientific areas that have high social value but minimal potential for profit. We briefly review the current market with an emphasis on the financing of innovative product development and propose ideas for new nonprofit companies centered on the health concerns of developed countries. We conclude with a suggestion that opportunities exist for nonprofit firms focused on cancer diagnostics, given the limitations of current financing incentives and ripe scientific opportunity.Entities:
Mesh:
Year: 2008 PMID: 18679181 PMCID: PMC4591870 DOI: 10.1038/clpt.2008.123
Source DB: PubMed Journal: Clin Pharmacol Ther ISSN: 0009-9236 Impact factor: 6.875